{
    "clinical_study": {
        "@rank": "67024", 
        "acronym": "MSVit", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D", 
                "arm_group_type": "Active Comparator", 
                "description": "treatment with weekly 50000IU vitamin D"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Treatment with placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Two hundred and forty patients with multiple sclerosis who met the study criteria will be\n      enrolled in this randomized double blind placebo-controlled clinical trial.\n\n      They will randomly assigned to placebo or vitamin D treatment group. The total time of study\n      is 52 weeks and the vitamin D group will be treated by weekly 50000 International unit(IU)\n      vitamin D, while the other group will receive weekly placebo. The annual relapse rate and\n      EDSS will be compared at baseline, month 6 and 12."
        }, 
        "brief_title": "Vitamine D in Multiple Sclerosis", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI:18-30kg/m2\n\n          -  caucasian race\n\n          -  Relapsing remitting multiple sclerosis\n\n          -  treatment with interferon beta\n\n        Exclusion Criteria:\n\n          -  Recent vitamin D supplement therapy\n\n          -  Restricted fat diet\n\n          -  nephrolithiasis in recent 5 years\n\n          -  Past history of hyperparathyroidism, sarcoidosis, cancer\n\n          -  Past history of hepatic disease\n\n          -  Past history of gastrointestinal disease\n\n          -  Past history of mycobacterial infection\n\n          -  Past history of hypercalcemia and hypercalciuria\n\n          -  serum creatinine>1.5\n\n          -  Smoking, drug abuse and corticosteroid therapy in recent year\n\n          -  treatment with thiazides or other drugs that inhibit vitamin D absorption\n\n          -  Disease attack in recent 2 months\n\n          -  Serum Ca>2.6mm0l/L\n\n          -  Serum 25(OH)D>85mmol/L\n\n          -  hypersensitivity to cholecalciferol\n\n          -  Past history of heart disease\n\n          -  Major depression\n\n          -  Uncontrolled hypertension (BP>180/110)\n\n          -  Immunosuppressive therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01768039", 
            "org_study_id": "MS-1191"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D", 
                "intervention_name": "Vitamin D", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamin E", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple sclerosis", 
            "Vitamin D", 
            "EDSS", 
            "ARR"
        ], 
        "lastchanged_date": "January 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sari", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Mazandaran"
                }, 
                "name": "Mazandaran University of medical sciences"
            }, 
            "investigator": {
                "last_name": "Mahmoud Abedini, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis", 
        "overall_contact": {
            "email": "mahmoudabedini@yahoo.com", 
            "last_name": "Mahmoud Abedini, MD", 
            "phone": "01513243158"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Iran: Mazandaran University of medical sciences", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Expanded disability state scale score (EDSS)", 
            "safety_issue": "No", 
            "time_frame": "Changes in EDSS from baseline to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01768039"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mazandaran University of Medical Sciences", 
            "investigator_full_name": "Mahmoud Abedini", 
            "investigator_title": "associate professor of neurology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Annual relapse rate(ARR)", 
            "safety_issue": "No", 
            "time_frame": "Changes in ARR from baseline to 12 months"
        }, 
        "source": "Mazandaran University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mazandaran University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}